NFE2L2 and cancer: Although the physiological context in which this phosphorylation pathway is modulated is unclear, Chowdhry et al. [47] reported that the inhibited GSK-3 pathway in cancer cells activates Nrf2 and confers drug resistance by upregulating anti-stress genes.